Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Climate change and interprovincial trade move grain production and environmental burdens northwards in China.

Nature food·2026
Same author

Integrated multi-omics profiling of treatment-naive cervix uteri premalignant lesions and cervical squamous cell carcinoma reveals ecosystem and drivers underlying cervical cancer progression.

Cell death & disease·2026
Same author

3D Printing for Pelvic Organ Prolapse Management: A Narrative Review of Emerging Applications.

Bioengineering (Basel, Switzerland)·2026
Same author

Amniotic Fluid Stem Cells in Birth Defects: Integrated Roles in Disease Modeling, Prenatal Diagnosis, and Therapy.

Stem cell reviews and reports·2026
Same author

Comparative analysis for optimal LSD1 inhibitors evaluation techniques: pros and cons.

Journal of pharmaceutical analysis·2026
Same author

Integrated climate effects on nitrogen cycles in global grasslands.

Science advances·2026
Same journal

RETRACTED: Alshabanah et al. Elastic Nanofibrous Membranes for Medical and Personal Protection Applications: Manufacturing, Anti-COVID-19, and Anti-Colistin Resistant Bacteria Evaluation. <i>Polymers</i> 2021, <i>13</i>, 3987.

Polymers·2026
Same journal

Correction: Kang et al. Energy-Saving Electrospinning with a Concentric Teflon-Core Rod Spinneret to Create Medicated Nanofibers. <i>Polymers</i> 2020, <i>12</i>, 2421.

Polymers·2026
Same journal

Influence of Self-Adhesive Resin Composite Deep Marginal Elevation on the Sealing Ability of CAD/CAM Lithium Disilicate Glass-Ceramic Inlays: An In Vitro Study.

Polymers·2026
Same journal

Modulating Exciton Dynamics Through Fluorescent Side Group Incorporation in Benzodithiophene-Benzotriazole-Isoindigo Terpolymers.

Polymers·2026
Same journal

PLA/PBSA Biocomposites Reinforced with Tangerine Tree-Derived Agro-Industrial Waste for Rigid Packaging: Effect of Extraction Treatment on Morphology and Thermo-Mechanical Performance.

Polymers·2026
Same journal

Synergistic Coatings Based on Chitosan and <i>Eugenia caryophyllata</i> Essential Oil to Improve Postharvest Quality of <i>Capsicum chinense</i>.

Polymers·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1&#945; Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

Polymer-Based Biomaterials for Local Therapy in Cervical Cancer: A Mini-Review.

Mingjing Qiao1, Xiaolong Wang1,2, Chenchen Ren1

  • 1Tianjian Laboratory of Advanced Biomedical Sciences, National Engineering Research Center for Advanced Polymer Processing Technology, Zhengzhou University, Zhengzhou 450002, China.

Polymers
|June 26, 2026
PubMed
Summary
This summary is machine-generated.

Polymer biomaterials offer advanced local therapies for cervical cancer, improving drug delivery and treatment precision. Further research is needed to overcome translational barriers for clinical application.

Keywords:
3D printingbrachytherapycervical cancergynecologic oncologylocal drug deliverypolymer-based biomaterials

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Related Experiment Videos

Last Updated: Jun 27, 2026

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1&#945; Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Area of Science:

  • Biomaterials Science
  • Oncology
  • Polymer Chemistry

Background:

  • Cervical cancer treatment faces challenges including poor drug delivery, systemic toxicity, and radiotherapy limitations.
  • Existing local treatment strategies lack precision and clinical adaptability.
  • There is a need for innovative biomaterial-based platforms for cervical cancer therapy.

Purpose of the Study:

  • To review polymer-based biomaterials for local cervical cancer therapy.
  • To discuss applications in drug delivery, tissue engineering, and radiotherapy.
  • To identify current challenges and future directions in the field.

Main Methods:

  • Mini-review of recent literature on polymer biomaterials for cervical cancer.
  • Analysis of applications including drug delivery systems (nanofibers, hydrogels), scaffolds, and 3D-printed radiotherapy devices.
  • Evaluation from both materials science and clinical perspectives.

Main Results:

  • Polymer-based local delivery systems enhance drug retention, controlled release, and local exposure.
  • Polymeric scaffolds provide sustained delivery, tissue support, and interaction.
  • 3D-printed radiotherapy devices improve precision, guidance, and conformity in challenging anatomies.

Conclusions:

  • Polymer biomaterials show significant promise for localized cervical cancer treatment.
  • Current research is largely preclinical, requiring more translational validation.
  • Future progress necessitates application-specific design, translational rigor, and integration with imaging and personalized medicine.